Public consultation on proposed revisions to the WHO Prequalification of in vitro diagnostics assessment process
IVD
Active Pharmaceutical Ingredient (API) Prequalified
M
Dolutegravir (sodium) manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Shanghai Desano’s nirmatrelvir + ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Sun Pharmaceutical’s atazanavir/ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Active Pharmaceutical Ingredient (API) Prequalified
M
Molnupiravir manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Active Pharmaceutical Ingredient (API) Prequalified
M
Tranexamic acid manufactured by Ami Lifesciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.